A 70-year-old man on ICU has chronic heart failure (EF 25%). He develops flash pulmonary oedema. After initial stabilisation with CPAP, GTN, and frusemide, the team considers his long-term heart failure medications. Which medication class has the strongest evidence for mortality reduction in heart failure with reduced ejection fraction (HFrEF)?